Imagene is a startup based in the United States, most recent round Series B, 3 tracked investors.
Imagene is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Imagene provides a disruptive, AI-based genomic testing solution to leverage the patient's historical data for personalized therapy, focusing on cancer diagnostic through pathological and molecular testing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.